Search Results : EPA National Library Catalog

Items Found: 47

Showing: Items 1 - 47

Your Search: (SUBJECT=Antineoplastic agents)

Sort Results:
Choose a Library:
(CTRL-CLICK for multiple libraries)
Choose a Collection:
(CTRL-CLICK for multiple collections)

Select Item Title Year Published
  1 Alleviation of Lake Pollution by Utilization of Aquatic Plants for Nutritional, Medicinal or Industrial Purposes. 1973
  2 Anticancer drug research 1987
  3 Antineoplastic agents 1984
  4 Antitumor natural products basic and clinical research / 1989
  5 Aquatic Plants from Minnesota. Part II. Toxicity, Anti-Neoplastic, and Coagulant Effects. 1972
  6 Basis for cancer management 1996
  7 Bioassay of 3,3'-iminobis-1-propanol dimethanesulfonate (ester) hydrochloride (IPD) for possible carcinogenicity. 1978
  8 Bioassay of estradiol mustard for possible carcinogenicity. 1978
  9 Bioassay of ICRF-159 for possible carcinogenicity. 1978
  10 Bioassay of isophosphamide for possible carcinogenicity. 1977
  11 Bioassay of thio-TEPA for possible carcinogenicity. 1978
  12 Biological response modifiers 1983
  13 Biological response modifiers, leukaemias and lymphomas 1987
  14 Characterization of Air Particulate Material for Polycyclic Aromatic Compounds. 1983
  15 Chemotherapy 1977
  16 Chlorinated Compounds Found in Waste-Treatment Effluents and Their Capacity to Bioaccumulate. 1976
  17 Computer-Automated Structure Evaluation of Antileukemic 9-Anilinoacridines. 1987
  18 Concept of Activity Profiles of Antimutagens. 1989
  19 Consideration of Pharmacokinetics and Temporal Sensitivity for Hydroxyurea in Relation to Teratogenic Potential. 1991
  20 Diesel Emissions Symposium proceedings / 1982
  21 DNA Adducts of the Antitumor Agent Diaziquone. 1992
  22 Effect of Chemotherapy on the In vivo Frequency of Glycophorin A 'Null' Variant Erythrocytes (Revised). 1990
  23 Effect of Dibutylnitrosamine and Saccharin on Glutamyl Transpeptidase-Positive Foci and Liver Cancer. 1983
  24 Efficient Multiple-Exposure Analysis of the Toxicity of Crisnatol: A DNA Intercalator in Phase 2 Clinical Trials. 1992
  25 Evaluation of the potential carcinogenicity of lead and lead compounds : in support of reportable quantity adjustments pursuant to CERCLA section 102. 1989
  26 Evaluation of the potential carcinogenicity of lead and lead compounds: in support of reportable quantity adjustments pursuant to CERCLA) {microform} / 1989
  27 Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations 1981
  28 Identification of selected Federal activities directed to chemicals of near-term concern : benzene, bis(chloromethyl) ether, cadmium, hydrogen sulfide, mercury, platinum, polynuclear aromatic hydrocarbons, trichloroethylene, tris(2, 3-dibromopropyl), phosphate / 1976
  29 Induction, Accumulation, and Persistence of Sister Chromatid Exchanges in Women with Breast Cancer Receiving Cyclophosphamide, Adriamycin, and 5-Fluorouracil Chemotherapy. 1990
  30 Inhibition of carcinogenesis 1971
  31 Inhibition of tumor induction and development 1981
  32 Laboratory decontamination and destruction of carcinogens in laboratory wastes : some antineoplastic agents / 1985
  33 Limitations of the Fluorescent Probe Viability Assay. 1989
  34 Manganese Chloride Enhances Murine Cell-Mediated Cytotoxicity: Effects on Natural Killer Cells. 1984
  35 Modifiers of chemical carcinogenesis an approach to the biochemical mechanism and cancer prevention / 1980
  36 Molecular and cellular biology of multidrug resistance in tumor cells 1991
  37 Molecular cancer therapeutics. 2001
  38 Monetizing the Pharmacological Benefits of Plants. 1991
  39 Persistence of SCE (Sister Chromatid Exchange)-Inducing Lesions in Lymphocytes of Mice Exposed to Diaziquone (Journal Version). 1988
  40 Principles of chemoprevention 1996
  41 Prolonged Survival of Female AKR Mice Fed Diets Supplemented with Methionine and Choline. 1990
  42 Some antineoplastic and immunosuppressive agents. 1981
  43 Some antiviral and antineoplastic drugs, and other pharmaceutical agents. 2000
  44 Structure-activity relationships of anti-tumour agents 1983
  45 Theoretical foundations of cancer chemotherapy introduced by computer models 1992
  46 Utility of the Murine Erythroleukemic Cell (MELC) in Assessing Mechanisms of Action of DNA-Active Developmental Toxicants: Application to 5-Fluorouracil. 1993
  47 Working group on molecular mechanisms of carcinogenic and antitumor activity, October 21-25, 1986 1987
Save, Print or Email Selected Records
Select Records Selected (this page only)
Selected (across pages)
All (this page only)
All (all pages - 500 item maximum)
Email Selected Records To: